drugset / Trial / NCT04622917

Methylprednisolone Injections Treating Birch Pollen Induced Allergic Rhinitis.

NCT04622917 ↗

Phase 4 Completed 44 enrolled Karolinska Institutet
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study evaluates the effect of intramuscular injected methylprednisolone treating birch pollen induced rhinitis compared to placebo.

Timeline

Start
2019-04-10
Primary completion
2022-06-20
Completion
2023-05-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylprednisolone Other / unclassified 2 ml Intramuscular
Comparator Methylprednisolone Other / unclassified 40 mg/ml Intramuscular